China International Capital Corporation Limited 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03908） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司2025 年面向專業機構投資者公開發行公司債券（第二期）票面利率公告，僅供參閱。 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 中國，北京 2025年8月22日 於本公告日期 ，本公司執行董事為陳亮先生；非執行董事為張薇女士及孔令岩先生； 以及獨立非執行董事為吳港平先生、陸正飛先生、彼得 • 諾蘭先生及周禹先生。 中国国际金融股份有限公司 2025 年面向专业机构投资者公开发 行公司债券（第二期）票面利率公告 2025 年 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 China International Capital Corporation Limited 中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03908） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司2023 年面向專業投資者非公開發行公司債券（第二期）（品種一）2025年票面利率調整公告，僅 供參閱。 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 债券简称:23 中金F3 中国国际金融股份有限公司 2023 年面向专业投资者非公开发行公司债券 (第二期)(品种一)2025年票面利率调整公告 本公司全体董事或具有同等职责的人员保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 ...

该行预期今轮股市升势将进一步延续，因目前市场杠杆水平温和且估值不高，估计潜在资金轮动或为股 市注入额外14万亿元人民币流动性，相当于可流通市值约16%。在券商股中首选中金公司(03908)、东方 财富（300059）(300059.SZ)及华泰证券（601688）(06886)，预期中金将最能受惠于中国内地及香港IPO 市场复苏与市况向好所带来的股权投资收益增长。小摩预期高息股将于第四季重拾动力，内银首选招商 银行（600036）(600036.SH)，同时亦推荐工商银行（601398）(01398)、中国银行（601988）(03988)及 交通银行（601328）(601328.SH)，均予"增持"评级。 摩根大通发布研报称，对中资银行及券商股持正面看法，建议投资者对中资金融股采用铃策略(Barbell Strategy)，即同时投资于高风险及低风险资产，预期市场资产轮动及过剩流动性增加，将成为股市上升 的关键驱动力。 ...

该行预期今轮股市升势将进一步延续，因目前市场杠杆水平温和且估值不高，估计潜在资金轮动或为股 市注入额外14万亿元人民币流动性，相当于可流通市值约16%。在券商股中首选中金公司(03908)、东方 财富(300059.SZ)及华泰证券(06886)，预期中金将最能受惠于中国内地及香港IPO市场复苏与市况向好所 带来的股权投资收益增长。小摩预期高息股将于第四季重拾动力，内银首选招商银行(600036.SH)，同 时亦推荐工商银行(01398)、中国银行(03988)及交通银行(601328.SH)，均予"增持"评级。 智通财经APP获悉，摩根大通发布研报称，对中资银行及券商股持正面看法，建议投资者对中资金融股 采用铃策略(Barbell Strategy)，即同时投资于高风险及低风险资产，预期市场资产轮动及过剩流动性增 加，将成为股市上升的关键驱动力。 ...

Group 1 - Investment opportunities in the US may arise from technology integration in non-sensitive sectors, while Europe presents opportunities in the carbon neutrality industry chain, and emerging markets are driven by resource endowments and policy directions [2] - Acquiring local brands when companies expand overseas can help quickly establish a presence, but retaining strong domestic brands is also viable if the brand has substantial strength [2] - Overseas acquisitions are a fast way to obtain key resources such as brands, technology, and channels, especially in consumer-facing sectors where there is still a bias against "Made in China" products [2] Group 2 - Retaining Chinese brands can be significant in industries or regional markets where Chinese companies have established technological advantages, as product performance may overshadow brand nationality [2] - Companies like DJI dominate the global drone market with over 80% market share, while Transsion has developed technologies tailored for the African smartphone market [2]

Core Viewpoint - The Beijing Equity Exchange has successfully completed its first online transfer of stock options, marking a significant milestone in the digitalization of financial services for innovative enterprises in Beijing [1][2]. Group 1: Transaction Details - The stock option transfer involved a high-tech enterprise focused on space laser communication technology, which is also a recipient of investment from Beijing's commercial aerospace and low-altitude economy industry fund [1]. - The transaction was facilitated by CITIC Bank's Beijing branch, which utilized a "loan + stock option" model to support the enterprise's development [1]. - All processes from registration confirmation, asset valuation, to transfer transaction were completed online, achieving a fully digital business cycle [1]. Group 2: Future Plans and Innovations - The Beijing Equity Exchange aims to enhance its role as a regional equity market by continuing to innovate in systems and business practices, thereby improving financing channels for innovative enterprises [2]. - The exchange plans to build a technology-finance linkage mechanism, enhancing capital efficiency and creating a distinctive technology finance service ecosystem in the capital [2].

Group 1 - On August 21, CICC's stock price decreased by 0.63%, with a trading volume of 926 million yuan [1] - The margin trading data shows that on the same day, CICC had a margin buy amount of 168 million yuan and a margin repayment of 113 million yuan, resulting in a net margin buy of approximately 55 million yuan [1] - As of August 21, the total margin trading balance for CICC was 2.462 billion yuan, with the margin balance accounting for 2.22% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - CICC, established on July 31, 1995, is headquartered in Beijing and operates in various financial services, including investment banking, equity sales and trading, fixed income, commodities, wealth management, and investment management [2] - The revenue composition of CICC's main business includes wealth management (32.73%), equity business (20.81%), fixed income (17.37%), investment banking (12.11%), other (8.25%), asset management (5.14%), and private equity (3.60%) [2] Group 3 - As of March 31, CICC had 139,600 shareholders, a decrease of 9.7% from the previous period, while the average circulating shares per person increased by 10.77% to 21,000 shares [3] - For the first quarter of 2025, CICC reported zero operating income but a net profit attributable to shareholders of 2.042 billion yuan, representing a year-on-year growth of 64.85% [3] Group 4 - Since its A-share listing, CICC has distributed a total of 4.924 billion yuan in dividends, with 2.607 billion yuan distributed over the past three years [4] - As of March 31, 2025, the top ten circulating shareholders of CICC included Hong Kong Central Clearing Limited as the third-largest shareholder, increasing its holdings by 1.1353 million shares to 49.5336 million shares [4]

Core Viewpoint - CICC's stock price has shown a positive trend, with a year-to-date increase of 15.12% and a market capitalization of 186.718 billion yuan as of August 22 [1][2]. Financial Performance - CICC's revenue for the first quarter of 2025 was reported at 0.00 yuan, while the net profit attributable to shareholders was 2.042 billion yuan, reflecting a year-on-year growth of 64.85% [3]. Stock Market Activity - On August 22, CICC's stock rose by 2.14%, with a trading volume of 633 million yuan and a turnover rate of 0.57% [1]. - The stock has experienced a 1.98% increase over the last five trading days, a 4.26% increase over the last 20 days, and a 16.86% increase over the last 60 days [2]. Shareholder Structure - As of March 31, 2025, CICC had 139,600 shareholders, a decrease of 9.70% from the previous period, with an average of 21,000 circulating shares per shareholder, an increase of 10.77% [3]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable changes in their holdings [4]. Business Segments - CICC's main business segments include wealth management (32.73% of revenue), equity sales and trading (20.81%), fixed income (17.37%), investment banking (12.11%), and others [2]. Dividend Distribution - Since its A-share listing, CICC has distributed a total of 4.924 billion yuan in dividends, with 2.607 billion yuan distributed in the last three years [4].

Core Viewpoint - The rare earth sector is experiencing a significant upward trend, with notable increases in stock prices and export volumes, indicating a positive outlook for the industry [1]. Export and Price Trends - In July, China's export of rare earth magnetic materials reached 5,577 tons, marking a year-on-year increase of 6% and a month-on-month increase of 75%. This figure exceeds the average level of the same period over the past three years by 10% [1]. - As of August 20, the domestic price of praseodymium and neodymium oxide was reported at 624,000 yuan per ton, reflecting a 57% increase since the beginning of the year and a 39% increase from the highest point in the first half of the year [1]. Demand and Supply Dynamics - According to estimates, the export volume of rare earth magnetic materials in 2024 is expected to account for approximately 24% of domestic total demand. The current peak season for downstream procurement, combined with improved export conditions, suggests a sustained positive trend in overall domestic demand for magnetic materials [1]. - Short-term projections indicate that domestic praseodymium and neodymium prices may continue to rise due to tightening supply and demand dynamics, driven by seasonal demand and limited supply increases from imports [1]. Long-term Outlook - In the medium to long term, from 2025 to 2027, the supply and demand for praseodymium and neodymium in China are expected to gradually tighten, leading to an upward shift in price levels [1]. - The strong performance of praseodymium and neodymium prices is supported by ongoing growth in downstream demand from sectors such as electric vehicles, air conditioning, and consumer electronics, as well as the acceleration of commercialization in humanoid robotics, which may open up new demand growth opportunities for rare earth permanent magnets [1].

Group 1 - The core viewpoint of the article is that China International Capital Corporation (CICC) has conducted a qualification review for the shareholders of Shanghai Mengke Pharmaceutical Co., Ltd. regarding their inquiry for share transfer to specific institutional investors [1][5] - CICC received a commission from the shareholders JSR Limited and Best Idea International Limited to organize the inquiry transfer [1] - The review process included verifying the registration certificates and compliance with relevant regulations for both JSR and Best Idea [2][4] Group 2 - JSR Limited was established on March 11, 2015, in the British Virgin Islands, and its main business is equity investment [2][3] - JSR has not violated any regulations regarding share reduction and is not a controlling shareholder of Mengke Pharmaceutical [3] - Best Idea International Limited was established on July 22, 2010, in Hong Kong, and its main business is also equity investment [4] - Best Idea has similarly complied with share reduction regulations and is not a controlling shareholder of Mengke Pharmaceutical [4][5] Group 3 - CICC concluded that both JSR and Best Idea meet the necessary qualifications for participating in the share inquiry transfer, with no violations of relevant regulations identified [5]